Cited In for PMID: 15987685

Year	Number of Results
2005	2
2006	5
2007	11
2008	12
2009	12
2010	9
2011	9
2012	10
2013	11
2014	10
2015	8
2016	8
2017	7
2018	10
2019	4
2020	11
2021	7
2022	14
2023	6
2024	3

1

Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes.

Keilhack H, David FS, McGregor M, Cantley LC, Neel BG. Keilhack H, et al. J Biol Chem. 2005 Sep 2;280(35):30984-93. doi: 10.1074/jbc.M504699200. Epub 2005 Jun 29. J Biol Chem. 2005. PMID: 15987685 Free article.

2

Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor.

Fasano G, Petrini S, Bonavolontà V, Paradisi G, Pedalino C, Tartaglia M, Lauri A. Fasano G, et al. Mol Med. 2024 Apr 9;30(1):47. doi: 10.1186/s10020-024-00807-w. Mol Med. 2024. PMID: 38594640 Free PMC article.

3

Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet.

Marasco M, Kirkpatrick J, Carlomagno T, Hub JS, Anselmi M. Marasco M, et al. Comput Struct Biotechnol J. 2024 Mar 2;23:1169-1180. doi: 10.1016/j.csbj.2024.02.023. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 38510972 Free PMC article.

4

Atomistic ensemble of active SHP2 phosphatase.

Anselmi M, Hub JS. Anselmi M, et al. Commun Biol. 2023 Dec 21;6(1):1289. doi: 10.1038/s42003-023-05682-5. Commun Biol. 2023. PMID: 38129686 Free PMC article.

5

SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities.

Liu Y, Zhang W, Jang H, Nussinov R. Liu Y, et al. Cell Mol Life Sci. 2023 Dec 12;81(1):5. doi: 10.1007/s00018-023-05052-8. Cell Mol Life Sci. 2023. PMID: 38085330

6

The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain.

van Vlimmeren AE, Voleti R, Chartier CA, Jiang Z, Karandur D, Humphries PA, Lo WL, Shah NH. van Vlimmeren AE, et al. bioRxiv [Preprint]. 2024 Apr 9:2023.07.10.548257. doi: 10.1101/2023.07.10.548257. bioRxiv. 2024. PMID: 37502916 Free PMC article. Preprint.

7

Experiment-guided molecular simulations define a heterogeneous structural ensemble for the PTPN11 tandem SH2 domains.

Marasco M, Kirkpatrick J, Carlomagno T, Hub JS, Anselmi M. Marasco M, et al. Chem Sci. 2023 May 4;14(21):5743-5755. doi: 10.1039/d3sc00746d. eCollection 2023 May 31. Chem Sci. 2023. PMID: 37265738 Free PMC article.

8

High-throughput profiling of sequence recognition by tyrosine kinases and SH2 domains using bacterial peptide display.

Li A, Voleti R, Lee M, Gagoski D, Shah NH. Li A, et al. Elife. 2023 Mar 16;12:e82345. doi: 10.7554/eLife.82345. Elife. 2023. PMID: 36927728 Free PMC article.

9

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation.

Sha F, Kurosawa K, Glasser E, Ketavarapu G, Albazzaz S, Koide A, Koide S. Sha F, et al. J Mol Biol. 2023 Apr 15;435(8):168010. doi: 10.1016/j.jmb.2023.168010. Epub 2023 Feb 16. J Mol Biol. 2023. PMID: 36806475 Free PMC article.

10

SH2 Domains: Folding, Binding and Therapeutical Approaches.

Diop A, Santorelli D, Malagrinò F, Nardella C, Pennacchietti V, Pagano L, Marcocci L, Pietrangeli P, Gianni S, Toto A. Diop A, et al. Int J Mol Sci. 2022 Dec 15;23(24):15944. doi: 10.3390/ijms232415944. Int J Mol Sci. 2022. PMID: 36555586 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

152 results

Results by year